Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment.
Respir Med
; 186: 106531, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1300990
ABSTRACT
The covid-19 pandemic has been affecting many countries across the world and lost precious lives. Most patients suffer from respiratory disease which progresses to the severe acute respiratory syndrome, termed as SARS-CoV-2 pneumonia. A systemic inflammatory response occurs in SARS-CoV-2 pneumonia severely ill patients, The inflammation process if uncontrolled has a detrimental effect, and the release of cytokines play an important role leading to lung fibrosis. Radiation therapy used in low doses has an anti-inflammatory and immunomodulatory effect. Its low cost, wider availability, and decreased risk of acute side effects can reduce the burden on the health care system.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Radiotherapy
/
Severe Acute Respiratory Syndrome
/
COVID-19
Type of study:
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Respir Med
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS